n-3脂肪酸生物标志物与新发2型糖尿病:20项前瞻性队列研究的个体参与者水平汇总分析
该研究汇总了来自14个国家20项前瞻性研究的65,147名基线无糖尿病且检测了n-3脂肪酸生物标志物的参与者,随访期间新发2型糖尿病16,693例。汇总多变量分析显示,海鲜来源的EPA、DPA、DHA及其总和每升高一个五分位间距与2型糖尿病风险降低相关,而植物来源的ALA无显著关联。
要点
- 海鲜来源n-3脂肪酸(EPA、DPA、DHA及总和)水平较高与2型糖尿病风险降低相关。
- 植物来源ALA生物标志物与2型糖尿病风险无显著关联。
- 关联在预设亚组和敏感性分析中稳健。
核心结论
- 海鲜来源n-3脂肪酸(EPA、DPA、DHA及总和)循环生物标志物较高与2型糖尿病风险降低相关。
- 植物来源ALA生物标志物与2型糖尿病风险无显著关联。
研究设计与样本
- 研究纳入来自14个国家20项前瞻性研究的65,147名基线无糖尿病且检测了ALA、EPA、DPA或DHA的参与者。
- 各队列按预设方案进行统一分析,采用逆方差加权荟萃分析汇总队列特异性关联。
主要发现
- 随访期间新发2型糖尿病16,693例,中位随访时间范围为2.5至21.2年。
- 每五分位间距(第90与第10百分位数之差),EPA与2型糖尿病风险的HR为0.92(95%CI 0.87, 0.96),P<0.001。
- 每五分位间距,DPA的HR为0.79(95%CI 0.73, 0.85),P<0.001。
- 每五分位间距,DHA的HR为0.82(95%CI 0.76, 0.89),P<0.001。
- 每五分位间距,EPA、DPA、DHA总和的HR为0.81(95%CI 0.75, 0.88),P<0.001;ALA的HR为0.97(95%CI 0.92, 1.02)。
临床怎么用
- 检测循环n-3脂肪酸生物标志物(EPA、DPA、DHA)可能有助于识别2型糖尿病风险较高的个体。
- 增加海鲜来源n-3脂肪酸摄入可能对2型糖尿病预防有益,但需结合个体情况。
局限性
- 研究为观察性设计,不能推断因果关系。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Prospective associations between n-3 fatty acid biomarkers and type 2 diabetes (T2D) risk are not consistent in individual studies. We aimed to summarize the prospective associations of biomarkers of α-linolenic acid (ALA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) with T2D risk through an individual participant-level pooled analysis. RESEARCH DESIGN AND METHODS: For our analysis we incorporated data from a global consortium of 20 prospective studies from 14 countries. We included 65,147 participants who had blood measurements of ALA, EPA, DPA, or DHA and were free of diabetes at baseline. De novo harmonized analyses were performed in each cohort following a prespecified protocol, and cohort-specific associations were pooled using inverse variance-weighted meta-analysis. RESULTS: A total of 16,693 incident T2D cases were identified during follow-up (median follow-up ranging from 2.5 to 21.2 years). In pooled multivariable analysis, per interquintile range (difference between the 90th and 10th percentiles for each fatty acid), EPA, DPA, DHA, and their sum were associated with lower T2D incidence, with hazard ratios (HRs) and 95% CIs of 0.92 (0.87, 0.96), 0.79 (0.73, 0.85), 0.82 (0.76, 0.89), and 0.81 (0.75, 0.88), respectively (all P < 0.001). ALA was not associated with T2D (HR 0.97 [95% CI 0.92, 1.02]) per interquintile range. Associations were robust across prespecified subgroups as well as in sensitivity analyses. CONCLUSIONS: Higher circulating biomarkers of seafood-derived n-3 fatty acids, including EPA, DPA, DHA, and their sum, were associated with lower risk of T2D in a global consortium of prospective studies. The biomarker of plant-derived ALA was not significantly associated with T2D risk.
引用
- Qian F, Ardisson Korat AV, Imamura F, et al. n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies. Diabetes Care. 2021. PMID: 33658295. doi:10.2337/dc20-2426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。